XML 149 R128.htm IDEA: XBRL DOCUMENT v3.6.0.2
Schedule II-Condensed Financial Information Of Registrant (Statement Of Cash Flows) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating activities                      
Net income $ 368.4 $ 617.8 $ 780.6 $ 703.0 $ 180.9 $ 654.8 $ 859.1 $ 865.2 $ 2,469.8 $ 2,560.0 $ 2,569.7
Adjustments to reconcile net income to net cash provided by operating activities:                      
Net realized losses on financial instruments                 (220.1) (147.1) (240.3)
Other-than-temporary impairment losses recognized in income                 115.4 83.4 49.0
(Gain) loss on extinguishment of debt                 0.0 (9.3) 81.1
Loss on disposal of assets                 4.5 16.0 (1.7)
Deferred income taxes                 126.9 (65.9) 30.7
Amortization, net of accretion                 807.8 802.1 744.5
Depreciation expense                 104.0 105.8 106.5
Share-based compensation                 164.6 148.2 168.9
Excess tax benefits from share-based compensation                 (53.5) (95.8) (46.4)
Changes in operating assets and liabilities:                      
Receivables, net                 (1,380.5) (42.9) (1,899.7)
Other invested assets, current                 (19.4) 5.9 (21.7)
Other assets                 (127.7) 33.8 405.5
Accounts payable and accrued expenses                 116.6 (219.3) (14.4)
Other liabilities                 605.7 686.4 (7.9)
Other, net                 (96.5) (5.1) (84.2)
Net cash provided by operating activities                 3,204.5 4,116.0 3,369.3
Investing activities                      
Changes in collateral and settlement of non-hedging derivatives                 (34.5) (36.5) (67.4)
Changes in securities lending collateral                 222.0 214.4 (545.6)
Other, net                 (3.0) (8.2) (0.1)
Net cash used in investing activities                 (513.9) (1,151.5) (974.9)
Financing activities                      
Net (repayments of) proceeds from commercial paper borrowings                 (53.2) 682.2 (379.2)
Proceeds from long-term borrowings                 0.0 1,226.5 2,700.0
Repayments of long-term borrowings                 0.0 (2,697.2) (1,730.1)
Changes in securities lending payable                 (222.0) (214.4) 545.6
Changes in bank overdrafts                 513.8 (243.8) 173.0
Premiums paid on equity call options                 0.0 (16.7) 0.0
Proceeds from sale of put options                 0.0 16.6 0.0
Repurchase and retirement of common stock                 0.0 (1,515.8) (2,998.8)
Change in collateral and settlements of debt-related derivatives                 (360.4) 0.0 0.0
Cash dividends (171.3) $ (171.1) $ (170.9) (170.7) (163.1) $ (163.0) $ (163.9) (166.6) (684.0) (656.6) (480.7)
Proceeds from issuance of common stock under employee stock plans                 119.4 186.0 301.3
Excess tax benefits from share-based compensation                 53.5 95.8 46.4
Net cash used in financing activities                 (732.9) (2,997.4) (1,822.5)
Change in cash and cash equivalents                 1,961.8 (38.2) 564.8
Cash and cash equivalents at beginning of year       2,113.5       2,151.7 2,113.5 2,151.7  
Cash and cash equivalents at end of year 4,075.3       2,113.5       4,075.3 2,113.5 2,151.7
Anthem, Inc. [Member]                      
Operating activities                      
Net income                 2,469.8 2,560.0 2,569.7
Adjustments to reconcile net income to net cash provided by operating activities:                      
(Undistributed) distributed earnings of subsidiaries                 (502.4) (287.8) 244.3
Net realized losses on financial instruments                 195.0 3.8 27.1
Other-than-temporary impairment losses recognized in income                 47.8 39.2 28.5
(Gain) loss on extinguishment of debt                 0.0 (9.3) 81.1
Loss on disposal of assets                 2.3 0.2 3.9
Deferred income taxes                 (7.0) 55.0 52.7
Amortization, net of accretion                 33.5 40.8 17.5
Depreciation expense                 70.4 68.1 67.4
Share-based compensation                 164.6 148.2 168.9
Excess tax benefits from share-based compensation                 (53.5) (95.8) (46.4)
Changes in operating assets and liabilities:                      
Receivables, net                 17.5 (17.9) (16.6)
Other invested assets, current                 1.3 (0.2) (3.8)
Other assets                 213.2 (106.9) 55.6
Amounts due from/to subsidiaries                 (1,487.8) 420.5 566.1
Accounts payable and accrued expenses                 (21.8) 7.5 (111.4)
Other liabilities                 (30.7) (231.4) (113.8)
Income taxes                 198.4 47.2 (36.0)
Other, net                 5.1 (10.2) 0.0
Net cash provided by operating activities                 1,315.7 2,631.0 3,554.8
Investing activities                      
Purchases of investments                 (2,874.9) (2,130.7) (1,819.3)
Proceeds from sales, maturities, calls and redemptions of investments                 3,309.8 3,076.6 820.7
Changes in collateral and settlement of non-hedging derivatives                 (34.5) (36.5) (67.4)
Capitalization of subsidiaries                 (295.0) (939.7) (321.8)
Changes in securities lending collateral                 91.8 94.0 (178.8)
Purchases of property and equipment, net of sales                 (98.7) (51.1) (57.0)
Other, net                 (7.9) 1.5 (38.0)
Net cash used in investing activities                 90.6 14.1 (1,661.6)
Financing activities                      
Net (repayments of) proceeds from commercial paper borrowings                 (53.2) 682.2 (379.2)
Proceeds from long-term borrowings                 0.0 1,226.5 2,700.0
Repayments of long-term borrowings                 0.0 (2,697.2) (1,730.1)
Changes in securities lending payable                 (90.9) (94.2) 178.6
Changes in bank overdrafts                 30.8 (89.3) 55.5
Premiums paid on equity call options                 0.0 (16.7) 0.0
Proceeds from sale of put options                 0.0 16.6 0.0
Repurchase and retirement of common stock                 0.0 (1,515.8) (2,998.8)
Change in collateral and settlements of debt-related derivatives                 (360.4) 0.0 0.0
Cash dividends                 (715.1) (686.5) (501.6)
Proceeds from issuance of common stock under employee stock plans                 119.4 186.0 301.3
Excess tax benefits from share-based compensation                 53.5 95.8 46.4
Net cash used in financing activities                 (1,015.9) (2,892.6) (2,327.9)
Change in cash and cash equivalents                 390.4 (247.5) (434.7)
Cash and cash equivalents at beginning of year       $ 492.3       $ 739.8 492.3 739.8 1,174.5
Cash and cash equivalents at end of year $ 882.7       $ 492.3       $ 882.7 $ 492.3 $ 739.8